Opaleye Management Inc. Graphite Bio, Inc. Transaction History

Opaleye Management Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.82 - $4.24 $330,645 - $497,140	117,250 Added 25.49%	577,250 $1.83 Million
Q2 2022 Aug 15, 2022	BUY	$2.14 - $5.23 $437,630 - $1.07 Million	204,500 Added 80.04%	460,000 $1.27 Million
Q1 2022 May 16, 2022	BUY	$5.1 - $13.06 $1.3 Million - $3.34 Million	255,500 New	255,500 $1.3 Million

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.